John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YSG
1376
Yatsen Holding
YSG
$280M
| $2.41M | 0.01% |
+28,312
| New | +$2.37M |
|
1377
CALL
General Dynamics
GD
$102B
| $2.4M | 0.01% |
16,100
+7,100
| +79% | +$1.04M |
|
1378
Silicon Laboratories
SLAB
$7.28B
| $2.4M | 0.01% |
18,818
-15,347
| -45% | -$1.73M |
|
1379
uniQure
QURE
$3.51B
| $2.39M | 0.01% |
66,166
-57,972
| -47% | -$2.45M |
|
1380
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$33.1B
| $2.39M | 0.01% |
+27,000
| New | +$2.27M |
|
1381
CALL
Bloom Energy
BE
$63.8B
| $2.39M | 0.01% |
83,400
+44,800
| +116% | +$956K |
|
1382
Horizon Technology Finance
HRZN
$321M
| $2.39M | 0.01% |
180,412
+24,836
| +16% | +$310K |
|
|
SKX
1383
PUT
DELISTED
Skechers
SKX
| $2.38M | 0.01% |
66,300
+33,200
| +100% | +$1.13M |
|
1384
BOK Financial
BOKF
$8.44B
| $2.38M | 0.01% |
+34,760
| New | +$2.24M |
|
1385
Neurogene
NGNE
$825M
| $2.38M | 0.01% |
8,437
+1,120
| +15% | +$274K |
|
|
UCTT
1386
Ultra Clean Holdings
UCTT
$3.3B
| $2.38M | 0.01% |
+76,388
| New | +$2.13M |
|
1387
PUT
GDS Holdings
GDS
$6.55B
| $2.38M | 0.01% |
25,400
+6,100
| +32% | +$542K |
|
|
RADA
1388
DELISTED
Rada Electronic Industries Ltd
RADA
| $2.37M | 0.01% |
243,506
+155,992
| +178% | +$1.2M |
|
1389
CALL
Carnival Corporation Ltd
CCL
$35.4B
| $2.37M | 0.01% |
109,200
-106,800
| -49% | -$1.9M |
|
1390
Anika Therapeutics
ANIK
$286M
| $2.36M | 0.01% |
52,234
+7,082
| +16% | +$269K |
|
1391
CALL
Cloudflare
NET
$98.4B
| $2.36M | 0.01% |
31,100
-86,500
| -74% | -$5.67M |
|
1392
Ambev
ABEV
$44.7B
| $2.36M | 0.01% |
770,814
-2,724,897
| -78% | -$7.35M |
|
|
GAP
1393
CALL
The Gap Inc
GAP
$7.26B
| $2.36M | 0.01% |
116,700
+30,200
| +35% | +$634K |
|
1394
ANI Pharmaceuticals
ANIP
$1.72B
| $2.35M | 0.01% |
81,032
+5,497
| +7% | +$157K |
|
1395
PUT
American Airlines Group
AAL
$9.12B
| $2.35M | 0.01% |
149,000
-1,094,800
| -88% | -$15.2M |
|
1396
Kraft Heinz
KHC
$30B
| $2.35M | 0.01% |
67,798
+41,600
| +159% | +$1.35M |
|
1397
CALL
Prudential Financial
PRU
$41.4B
| $2.34M | 0.01% |
30,000
+14,000
| +88% | +$1.01M |
|
|
CMRC
1398
Commerce.com Inc Series 1
CMRC
$190M
| $2.34M | 0.01% |
+36,431
| New | +$2.91M |
|
1399
CALL
PennyMac Financial
PFSI
$3.83B
| $2.33M | 0.01% |
35,500
+12,200
| +52% | +$726K |
|
1400
CALL
Thermo Fisher Scientific
TMO
$232B
| $2.33M | 0.01% |
5,000
+4,200
| +525% | +$1.97M |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.